EXACT Therapeutics AS (OSL:EXTX)
Norway
· Delayed Price · Currency is NOK 1.480
+0.050 (3.50%)
At close: Apr 28, 2026
EXACT Therapeutics AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 24.35 | 99.54 | 46.43 | 69.39 | 82.91 | Upgrade
|
| Short-Term Investments | - | - | - | - | 20.78 | Upgrade
|
| Cash & Short-Term Investments | 24.35 | 99.54 | 46.43 | 69.39 | 103.69 | Upgrade
|
| Cash Growth | -75.54% | 114.38% | -33.09% | -33.08% | -35.08% | Upgrade
|
| Other Receivables | 7 | 6.69 | 8.64 | 8.14 | 7.61 | Upgrade
|
| Receivables | 7 | 6.69 | 8.64 | 8.14 | 7.61 | Upgrade
|
| Other Current Assets | 29.16 | 26.98 | 0.83 | - | - | Upgrade
|
| Total Current Assets | 60.51 | 133.21 | 55.9 | 77.53 | 111.3 | Upgrade
|
| Property, Plant & Equipment | 6.89 | 4.81 | 5.42 | 4.97 | 6.33 | Upgrade
|
| Other Long-Term Assets | - | 15.19 | 0 | 0 | - | Upgrade
|
| Total Assets | 67.4 | 153.2 | 61.32 | 82.51 | 117.63 | Upgrade
|
| Accounts Payable | 7.45 | 11.66 | 7.21 | 9.55 | 3.18 | Upgrade
|
| Accrued Expenses | 9.59 | 7.27 | 6.17 | 4.71 | 6.33 | Upgrade
|
| Current Portion of Leases | 0.43 | 0.59 | 0.55 | 0.5 | 0.36 | Upgrade
|
| Other Current Liabilities | 19.22 | 18.08 | 1.56 | 1.37 | 0.66 | Upgrade
|
| Total Current Liabilities | 36.69 | 37.6 | 15.49 | 16.13 | 10.53 | Upgrade
|
| Long-Term Leases | - | 0.05 | 0.65 | 1.19 | 1.35 | Upgrade
|
| Other Long-Term Liabilities | 0 | - | 0.12 | 0.08 | 0 | Upgrade
|
| Total Liabilities | 36.69 | 37.65 | 16.26 | 17.4 | 11.89 | Upgrade
|
| Common Stock | 0.25 | 0.25 | 0.13 | 0.12 | 0.12 | Upgrade
|
| Additional Paid-In Capital | 9.67 | 96.64 | 29.44 | 93.52 | 215.63 | Upgrade
|
| Retained Earnings | - | - | - | -40.1 | -122.01 | Upgrade
|
| Comprehensive Income & Other | 20.78 | 18.65 | 15.49 | 11.57 | 12.01 | Upgrade
|
| Shareholders' Equity | 30.71 | 115.55 | 45.06 | 65.11 | 105.74 | Upgrade
|
| Total Liabilities & Equity | 67.4 | 153.2 | 61.32 | 82.51 | 117.63 | Upgrade
|
| Total Debt | 0.43 | 0.65 | 1.2 | 1.69 | 1.71 | Upgrade
|
| Net Cash (Debt) | 23.91 | 98.89 | 45.23 | 67.7 | 101.97 | Upgrade
|
| Net Cash Growth | -75.82% | 118.61% | -33.19% | -33.61% | -36.14% | Upgrade
|
| Net Cash Per Share | 0.38 | 2.85 | 1.41 | 2.26 | 3.40 | Upgrade
|
| Filing Date Shares Outstanding | 63.26 | 63.26 | 32.08 | 30 | 29.99 | Upgrade
|
| Total Common Shares Outstanding | 63.26 | 63.26 | 32.08 | 30 | 29.99 | Upgrade
|
| Working Capital | 23.82 | 95.61 | 40.41 | 61.41 | 100.76 | Upgrade
|
| Book Value Per Share | 0.49 | 1.83 | 1.40 | 2.17 | 3.53 | Upgrade
|
| Tangible Book Value | 30.71 | 115.55 | 45.06 | 65.11 | 105.74 | Upgrade
|
| Tangible Book Value Per Share | 0.49 | 1.83 | 1.40 | 2.17 | 3.53 | Upgrade
|
| Machinery | 18.14 | 12.96 | 11.28 | 8.22 | 8.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.